Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • wdt
    Member
    • Oct 2009
    • 19

    #16
    Hello,

    Could someone please provide more description of each field in the info string?

    DP=2;AF1=1;CI95=0.5,1;DP4=0,0,0,2;MQ=43 PL:GT:GQ 39,6,0:1/1:49

    I know that DP is depth of coverage. What are AF1, CI95 (confidence interval?), DP4?

    Are 39,6,0 showing AA:AB:BB (guess)? Then should they be related to to the DP value?

    For multiple sample case, is there a way to find allelic frequency for each
    sample using the INFO field? Can someone show an example?





    The documentation on VCF4.0 http://www.1000genomes.org/wiki/Anal...mat-version-40

    seems to have skipped the explanation for these fields.

    Any help with this will be most appreciated. Thanks all, this is a terrific forum.

    --------

    I found the answers at http://samtools.sourceforge.net/mpileup.shtml. It is well-explained there.
    Last edited by wdt; 12-09-2010, 01:40 PM. Reason: Found the answer

    Comment

    • cboustred
      Member
      • May 2010
      • 11

      #17
      Hi wdt, see http://samtools.sourceforge.net/mpileup.shtml for a description of the fields.

      I'm a newbie to all this NGS business so cannot expand on what they all mean, I'm slowly trying to work it out for myself!

      Good luck

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        Today, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 02:55 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Working...